Lange JM - Search Results

1

Long-term zidovudine treatment of asymptomatic HIV-1-infected subjects.

Mulder JW, de Wolf F, Goudsmit J, Cload PA, Coutinho RA, Fiddian AP, Schellekens PT, van der Noordaa J, Lange JM. Mulder JW, et al. Among authors: lange jm. Antiviral Res. 1990 Mar;13(3):127-38. doi: 10.1016/0166-3542(90)90028-6. Antiviral Res. 1990. PMID: 1972321

2

Dehydroepiandrosterone as predictor for progression to AIDS in asymptomatic human immunodeficiency virus-infected men.

Mulder JW, Frissen PH, Krijnen P, Endert E, de Wolf F, Goudsmit J, Masterson JG, Lange JM. Mulder JW, et al. Among authors: lange jm. J Infect Dis. 1992 Mar;165(3):413-8. doi: 10.1093/infdis/165.3.413. J Infect Dis. 1992. PMID: 1347053

3

Ordered appearance of zidovudine resistance mutations during treatment of 18 human immunodeficiency virus-positive subjects.

Boucher CA, O'Sullivan E, Mulder JW, Ramautarsing C, Kellam P, Darby G, Lange JM, Goudsmit J, Larder BA. Boucher CA, et al. Among authors: lange jm. J Infect Dis. 1992 Jan;165(1):105-10. doi: 10.1093/infdis/165.1.105. J Infect Dis. 1992. PMID: 1370174

4

Differences in clinical course in zidovudine-treated asymptomatic HIV-infected men associated with T-cell function at intake.

Gruters RA, Terpstra FG, Lange JM, Roos MT, Harkema T, Mulder JW, De Wolf F, Schellekens PT, Miedema F. Gruters RA, et al. Among authors: lange jm. AIDS. 1991 Jan;5(1):43-7. doi: 10.1097/00002030-199101000-00006. AIDS. 1991. PMID: 1676272

5

Contribution of antibody response to recombinant HIV-1 gene-encoded products nef, rev, tat, and protease in predicting development of AIDS in HIV-1-infected individuals.

Reiss P, de Wolf F, Kuiken CL, de Ronde A, Dekker J, Boucher CA, Debouck C, Lange JM, Goudsmit J. Reiss P, et al. Among authors: lange jm. J Acquir Immune Defic Syndr (1988). 1991;4(2):165-72. J Acquir Immune Defic Syndr (1988). 1991. PMID: 1898969

6

Serum beta 2-microglobulin levels in asymptomatic HIV-1-infected subjects during long-term zidovudine treatment.

Mulder JW, Krijnen P, Coutinho RA, Bakker M, Goudsmit J, Lange JM. Mulder JW, et al. Among authors: lange jm. Genitourin Med. 1991 Jun;67(3):188-93. doi: 10.1136/sti.67.3.188. Genitourin Med. 1991. PMID: 1906425 Free PMC article.

7

Zidovudine sensitivity of human immunodeficiency viruses from high-risk, symptom-free individuals during therapy.

Boucher CA, Tersmette M, Lange JM, Kellam P, de Goede RE, Mulder JW, Darby G, Goudsmit J, Larder BA. Boucher CA, et al. Among authors: lange jm. Lancet. 1990 Sep 8;336(8715):585-90. doi: 10.1016/0140-6736(90)93391-2. Lancet. 1990. PMID: 1975378

8

HIV-1 P24 antigenaemia does not predict time of survival in AIDS patients.

Mulder JW, Krijnen P, Goudsmit J, Schattenkerk JK, Reiss P, Lange JM. Mulder JW, et al. Among authors: lange jm. Genitourin Med. 1990 Jun;66(3):138-41. doi: 10.1136/sti.66.3.138. Genitourin Med. 1990. PMID: 2115018 Free PMC article.

9

Serum p24 antigen levels in untreated and zidovudine-treated HIV-1 infected subjects.

Mulder JW, Lange JM, de Wolf F, Houweling JT, Bakker M, Coutinho RA, Goudsmit J. Mulder JW, et al. Among authors: lange jm. Neth J Med. 1990 Aug;37(1-2):4-10. Neth J Med. 1990. PMID: 2120599

10

Low T-cell responsiveness to activation via CD3/TCR is a prognostic marker for acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus-1 (HIV-1)-infected men.

Schellekens PT, Roos MT, De Wolf F, Lange JM, Miedema F. Schellekens PT, et al. Among authors: lange jm. J Clin Immunol. 1990 Mar;10(2):121-7. doi: 10.1007/BF00918194. J Clin Immunol. 1990. PMID: 2140115

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

460 results

Search Page

Filters